Skip to main content
. 2021 Jul 27;21:862. doi: 10.1186/s12885-021-08612-y

Table 2.

Objective Response

Objective response (n, %) Everolimus plus letrozole (n = 20) FEC (n = 20)
Complete response 0 (0.0) 0 (0.0)
Partial response 13 (65.0) 8 (40.0)
Stable disease 6 (30.0) 10 (50.0)
Progressive disease 1 (5.0) 2 (10.0)